RASEF is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer
Hideto Oshita(Hiroshima University), Yataro Daigo(The University of Tokyo), Eiju Tsuchiya(Kanagawa Prefectural Hospital Organization), Tatsuya Kato(Toranomon Hospital), Hirohiko Akiyama(Hiroshima University), Atsushi Takano(The University of Tokyo), Yusuke Nakamura(Rissho University), Ryohei Nishino(The University of Tokyo), Masato Aragaki(Sapporo Minami Hospital), Nobuoki Kohno(Hiroshima University), Takashi Fujitomo(Shiga University of Medical Science)
Cited by 26
Related Papers
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593